Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL at 6: Filled with critters and abandoned for a decade - WRAL Investigates whoâs responsible when a home becomes a health hazard.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tracon Pharmaceuticals Inc
(NQ:
TCON
)
1.430
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tracon Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
TRACON Touts Encouraging Objective Response Rates For Mid-Stage Cancer Study
December 14, 2022
Via
Benzinga
TRACON Pharmaceuticals Announces Positive Results Based on Double-Digit Objective Response Rate in Each Cohort from the Ongoing ENVASARC Phase 2 Pivotal Trial
December 14, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Combination with Envafolimab and Doxorubicin in Front Line Sarcoma
November 21, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON Shares Ascend On FDA Fast Track Status To Soft Tissue Cancer Candidate
September 14, 2022
The U.S.
Via
Benzinga
TRACON Secures FDA Nod For Early-Stage Study In Soft-Tissue Cancer
August 29, 2022
Via
Benzinga
Earnings Scheduled For November 14, 2022
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
TRACON Seeks FDA Nod For Initial-Stage Tissue Cancer Study
August 08, 2022
TRACON Pharmaceuticals (NASDAQ: TCON) has submitted an Investigational New Drug (IND) application to the U.S.
Via
Benzinga
TRACON Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
November 07, 2022
The Dow Jones jumped by over 400 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...
Via
Benzinga
TRACON to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 14, 2022
October 31, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying
October 20, 2022
The Dow Jones dropped by around 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Week In Review: AIM Vaccine Stages $20 Million IPO On Hong Kong Exchange
October 08, 2022
Beijing AIM Vaccine conducted a very small IPO on the Hong Kong exchange, raising just $20 million, which netted the company only $10 million. Interest in the offering was low, with less than 1% of the...
Via
Talk Markets
TRACON Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
October 06, 2022
US gold futures traded slightly higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Runway Growth Finance Corp. Provides Third Quarter 2022 Portfolio Update
October 06, 2022
From
Runway Growth Finance Corp.
Via
GlobeNewswire
TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of 12 Week Safety Data from ENVASARC Phase 2 Pivotal Trial - Trial to Proceed as Planned
October 06, 2022
Review of Interim Efficacy Data by IDMC to Occur in Fourth Quarter
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks.
Via
InvestorPlace
$1.2 Million Bet On ChromaDex? Check Out These 4 Penny Stocks Insiders Are Buying
October 04, 2022
The Dow Jones jumped by more than 750 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Cyclo Therapeutics, TRACON Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
September 23, 2022
The Dow Jones dropped by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 30, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 30, 2022
It's time for another breakdown of the biggest pre-market stock movers as we go over the latest news on Tuesday morning.
Via
InvestorPlace
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 10, 2022
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap of Monday's Biotech Catalysts - End Of the Day Summary
August 08, 2022
Via
Benzinga
BitNile And 1 Other Stock Under $2 Insiders Are Aggressively Buying
July 18, 2022
Bank of America (NYSE: BAC) reported weaker-than-expected results for its second quarter. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
4 Stocks Under $2 Insiders Are Aggressively Buying: NEXGEL, eFFECTOR Therapeutics And More
June 28, 2022
U.S. crude oil futures traded higher by over 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
June 27, 2022
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 24, 2022
Via
Benzinga
$1.1 Million Bet On TRACON Pharmaceuticals? 4 Penny Stocks Insiders are Buying
June 24, 2022
U.S. stocks opened sharply higher on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.